Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.
NCT01785914 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2013-02-07
Summary
This study provides for the collection of a series composed by patients with newly diagnosed of acute lymphoblastic leukemia in the period 1999-2011. This collection is carried out with retrospective investigation, through the review of paper and electronic records and data cards in large part already collected as part of study protocols "GIMEMA" or "BFM" or "NILG" approved by the Ethics Committee of Hospital. The purpose of data collection is to check with retrospective predictability of classical risk factors in relation to disease response, and overall survival of the event-free survival, to estimate the cumulative incidence of competitive events such as the emergence of disease, acute and chronic transplant, the transplant-related mortality and relapse of disease.
Conditions
- Disease: Acute Lymphoblastic Leukemia
Sponsors & Collaborators
-
Azienda Ospedaliera San Giovanni Battista
lead OTHER
Principal Investigators
-
Benedetto Bruno, MD · Divisione di Ematologia-Città della Salute e della Scienza di Torino
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-02-28
- Completion
- 2014-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
NCT05306301 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
NCT01699217 ·Status: COMPLETED
-
Identification of BCR::ABL1 Mutations by Digital PCR in CML
NCT07158294 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Leukemia
NCT00917540 ·Status: UNKNOWN
-
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients
NCT02010931 ·Status: COMPLETED
-
Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
NCT01578213 ·Status: COMPLETED ·Phase: PHASE4
-
French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients
NCT05619978 ·Status: COMPLETED
-
First Report, Five Years Experience of the Acute Leukemia Work Group
NCT02990104 ·Status: UNKNOWN
-
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735 ·Status: RECRUITING
-
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01185886 ·Status: UNKNOWN
-
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
NCT04070807 ·Status: UNKNOWN
-
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
NCT03367299 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program
NCT02582320 ·Status: COMPLETED
-
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
NCT00621244 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT03318770 ·Status: UNKNOWN
-
Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT01593488 ·Status: UNKNOWN ·Phase: PHASE2
-
A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
NCT00923182 ·Status: COMPLETED ·Phase: PHASE1
-
National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent
NCT02903277 ·Status: UNKNOWN
-
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
NCT06110182 ·Status: ACTIVE_NOT_RECRUITING
-
Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL
NCT06658925 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
NCT05611216 ·Status: COMPLETED
-
Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE
NCT01491763 ·Status: UNKNOWN ·Phase: PHASE4
-
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
NCT05310591 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
NCT01625143 ·Status: COMPLETED
-
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
NCT01724177 ·Status: COMPLETED ·Phase: PHASE2